vs

Side-by-side financial comparison of COMERICA INC (CMA) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

COMERICA INC is the larger business by last-quarter revenue ($838.0M vs $665.5M, roughly 1.3× Natera, Inc.). COMERICA INC runs the higher net margin — 21.0% vs 7.1%, a 13.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 3.3%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs 34.5%).

Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

CMA vs NTRA — Head-to-Head

Bigger by revenue
CMA
CMA
1.3× larger
CMA
$838.0M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+36.5% gap
NTRA
39.8%
3.3%
CMA
Higher net margin
CMA
CMA
13.9% more per $
CMA
21.0%
7.1%
NTRA
Faster 2-yr revenue CAGR
CMA
CMA
Annualised
CMA
108.9%
34.5%
NTRA

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CMA
CMA
NTRA
NTRA
Revenue
$838.0M
$665.5M
Net Profit
$176.0M
$47.3M
Gross Margin
Operating Margin
-3.4%
Net Margin
21.0%
7.1%
Revenue YoY
3.3%
39.8%
Net Profit YoY
-4.3%
187.9%
EPS (diluted)
$1.35
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMA
CMA
NTRA
NTRA
Q4 25
$665.5M
Q3 25
$838.0M
$592.2M
Q2 25
$849.0M
$546.6M
Q1 25
$829.0M
$501.8M
Q4 24
$825.0M
$476.1M
Q3 24
$811.0M
$439.8M
Q2 24
$824.0M
$413.4M
Q1 24
$784.0M
$367.7M
Net Profit
CMA
CMA
NTRA
NTRA
Q4 25
$47.3M
Q3 25
$176.0M
$-87.5M
Q2 25
$199.0M
$-100.9M
Q1 25
$172.0M
$-66.9M
Q4 24
$170.0M
$-53.8M
Q3 24
$184.0M
$-31.6M
Q2 24
$206.0M
$-37.5M
Q1 24
$138.0M
$-67.6M
Operating Margin
CMA
CMA
NTRA
NTRA
Q4 25
-3.4%
Q3 25
-16.5%
Q2 25
-20.2%
Q1 25
-15.8%
Q4 24
-13.6%
Q3 24
-8.9%
Q2 24
-10.6%
Q1 24
-20.2%
Net Margin
CMA
CMA
NTRA
NTRA
Q4 25
7.1%
Q3 25
21.0%
-14.8%
Q2 25
23.4%
-18.5%
Q1 25
20.7%
-13.3%
Q4 24
20.6%
-11.3%
Q3 24
22.7%
-7.2%
Q2 24
25.0%
-9.1%
Q1 24
17.6%
-18.4%
EPS (diluted)
CMA
CMA
NTRA
NTRA
Q4 25
$0.36
Q3 25
$1.35
$-0.64
Q2 25
$1.42
$-0.74
Q1 25
$1.25
$-0.50
Q4 24
$1.22
$-0.41
Q3 24
$1.33
$-0.26
Q2 24
$1.49
$-0.30
Q1 24
$0.98
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMA
CMA
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$5.4B
Stockholders' EquityBook value
$7.4B
$1.7B
Total Assets
$77.4B
$2.4B
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMA
CMA
NTRA
NTRA
Q4 25
Q3 25
$1.0M
Q2 25
$16.0M
Q1 25
$17.8M
Q4 24
$22.7M
Q3 24
$29.5M
Q2 24
$90.3M
Q1 24
$69.1M
Total Debt
CMA
CMA
NTRA
NTRA
Q4 25
Q3 25
$5.4B
Q2 25
$5.8B
Q1 25
$5.7B
Q4 24
$6.7B
Q3 24
$6.8B
Q2 24
$7.1B
Q1 24
$7.1B
Stockholders' Equity
CMA
CMA
NTRA
NTRA
Q4 25
$1.7B
Q3 25
$7.4B
$1.3B
Q2 25
$6.9B
$1.2B
Q1 25
$7.1B
$1.2B
Q4 24
$6.5B
$1.2B
Q3 24
$7.4B
$878.5M
Q2 24
$6.2B
$836.5M
Q1 24
$6.0B
$794.1M
Total Assets
CMA
CMA
NTRA
NTRA
Q4 25
$2.4B
Q3 25
$77.4B
$1.8B
Q2 25
$78.0B
$1.8B
Q1 25
$77.6B
$1.7B
Q4 24
$79.3B
$1.7B
Q3 24
$79.7B
$1.6B
Q2 24
$79.6B
$1.5B
Q1 24
$79.4B
$1.5B
Debt / Equity
CMA
CMA
NTRA
NTRA
Q4 25
Q3 25
0.73×
Q2 25
0.84×
Q1 25
0.81×
Q4 24
1.02×
Q3 24
0.92×
Q2 24
1.15×
Q1 24
1.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMA
CMA
NTRA
NTRA
Operating Cash FlowLast quarter
$-270.0M
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
-1.53×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMA
CMA
NTRA
NTRA
Q4 25
$73.9M
Q3 25
$-270.0M
$59.4M
Q2 25
$476.0M
$37.6M
Q1 25
$273.0M
$44.5M
Q4 24
$601.0M
$52.9M
Q3 24
$1.0B
$51.8M
Q2 24
$111.0M
$4.0M
Q1 24
$-205.0M
$27.0M
Free Cash Flow
CMA
CMA
NTRA
NTRA
Q4 25
$37.8M
Q3 25
$37.0M
Q2 25
$11.7M
Q1 25
$22.6M
Q4 24
$34.8M
Q3 24
$35.5M
Q2 24
$-7.7M
Q1 24
$6.7M
FCF Margin
CMA
CMA
NTRA
NTRA
Q4 25
5.7%
Q3 25
6.2%
Q2 25
2.1%
Q1 25
4.5%
Q4 24
7.3%
Q3 24
8.1%
Q2 24
-1.9%
Q1 24
1.8%
Capex Intensity
CMA
CMA
NTRA
NTRA
Q4 25
5.4%
Q3 25
3.8%
Q2 25
4.7%
Q1 25
4.3%
Q4 24
3.8%
Q3 24
3.7%
Q2 24
2.8%
Q1 24
5.5%
Cash Conversion
CMA
CMA
NTRA
NTRA
Q4 25
1.56×
Q3 25
-1.53×
Q2 25
2.39×
Q1 25
1.59×
Q4 24
3.54×
Q3 24
5.70×
Q2 24
0.54×
Q1 24
-1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons